ARTICLES BY THIS AUTHOR
- 6/8/2021
NACDS op-ed reinforces pharmacies’ continued role in COVID-19 vaccinations
NACDS chair Colleen Lindholz and vice chair Brian Nightengale emphasized pharmacies’ continued role in fostering vaccine confidence and ensuring equitable access to COVID-19 vaccines. - 6/8/2021
CVS Health completes rollout of time-delay safes in Georgia pharmacies
All 355 CVS Pharmacy locations in Georgia are now using time-delay safe technology. - 6/8/2021
Hy-Vee to enhance digital capabilities via Google Cloud partnership
Hy-Vee is using Google Cloud services to make online shopping easier for e-commerce shoppers, integrate its virtual dietitian services and enable customers to schedule vaccinations online. - 6/8/2021
CVS Health opens MinuteClinic locations in Utah
CVS Health has opened six MinuteClinic locations in Utah. - 6/8/2021
FDA approves Pfizer’s Prevnar 20 vaccine
Prevnar 20 is a vaccine to prevent invasive disease and pneumonia caused by 20 serotypes of pneumococcus. - 6/8/2021
Patrick Genestin to lead Hikma's generics business development
Genestin previously served as vice president of business development and licensing, and mergers and acquisitions for the U.S. entity of Sandoz. - 6/7/2021
NACDS names Roszak to lead health-and-wellness strategy, policy
Sara Roszak, who also was elected president of the NACDS Foundation, most recently served as vice president of pharmacy care and health strategy at NACDS. - 6/7/2021
FDA accepts Lannett's generic Advair Diskus application
Advair Diskus had a market value of approximately $3 billion for the 12 months ending April 2021, although actual generic market values are expected to be lower. - 6/7/2021
CVS Health to collaborate with Biogen for Alzheimer’s screenings
As part of the partnership, CVS Health will offer cognitive screenings in several major metro areas via Project Health beginning in September. - 6/7/2021
AAM supports Biden admin’s 100-day supply chain review
The Association for Accessible Medicines said its members are ready to partner with the government to ensure that the generic supply chain remains strong.